The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 17, 2015

Filed:

Mar. 15, 2011
Applicants:

Derin C. Walters, Austin, TX (US);

Alan D. King, Highland, MD (US);

Anna-karin Roos, Spånga, SE;

Robert J. Walters, Severna Park, MD (US);

Inventors:

Richard E. Walters, Severna Park, MD (US);

Derin C. Walters, Austin, TX (US);

Alan D. King, Highland, MD (US);

Anna-Karin Roos, Spånga, SE;

Assignee:

Cellectis, Paris, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/30 (2006.01); A61M 31/00 (2006.01); A61M 35/00 (2006.01); A61N 1/32 (2006.01); A61K 39/12 (2006.01); C07K 14/005 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61N 1/327 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61N 1/306 (2013.01); C12N 2770/24122 (2013.01);
Abstract

An object of the invention is to provide a method and apparatus for the delivery of polynucleotide vaccines into mammalian skin cells to increase T cell response and to reduce pain and discomfort due to long electric waveform application and due to muscle contractions. The method for the delivery of polynucleotide vaccines into mammalian skin cells includes the steps of: (a.) administering a polynucleotide vaccine into the skin at an administration site, (b.) applying a needle electrode to the skin in the vicinity to the administration site, and (c.) applying a sequence of at least three single, operator-controlled, independently programmed, narrow interval electrical waveforms, which have pulse intervals that are less than 100 milliseconds, to deliver the polynucleotide vaccine into the skin cells by electroporation. The sequence of at least three waveforms has one, two, or three of the following characteristics (1) at least two of the at least three waveforms differ from each other in waveform amplitude, (2) at least two of the at least three waveforms differ from each other in waveform width, and (3) a first waveform interval for a first set of two of the at least three waveforms is different from a second waveform interval for a second set of two of the at least three waveforms.


Find Patent Forward Citations

Loading…